Balaji Prasad analyst BARCLAYS

Currently, out of the existing stock ratings of Balaji Prasad - 15 which are a Sell (11.81%), 102 which are a Buy (80.31%), 10 which are a Hold (7.87%)

Balaji Prasad

Work Performance Price Targets & Ratings Chart

Analyst Balaji Prasad works at BARCLAYS and is covering the Healthcare sector with 255 price targets and ratings displayed on 21 stocks.

Balaji Prasad's average stock forecast success ratio is 49.16% with an average time for price targets to be met of 190.76 days.

Most recent stock forecast was given on IDXX, IDEXX Laboratories at 02-Nov-2023.

Wall Street Analyst Balaji Prasad

Analyst best performing recommendations are on MNK.
The best stock recommendation documented was for MNK at 4/2/2020. The price target of $3 was fulfilled within 7 days with a profit of $1.2 (66.67%) receiving and performance score of 95.24.

Average potential price target upside

BHC Bausch Health Companies CHRS Coherus BioSciences ELAN Elanco Animal Health ENDP Endo International plc EOLS Evolus IDXX IDEXX Laboratories JAZZ Jazz Pharmaceuticals plc LGND Ligand Pharmaceuticals PAHC PCRX Pacira BioSciences RDY Dr. Reddy's Laboratories RVNC Revance Therapeutics TEVA Teva Pharmaceutical Industries ZTS Zoetis VTRS AMAG AMRX Amneal Pharmaceuticals CVET Covetrus MNK PYPD RVLP

Analyst name


Current price target

Potential distance

Previous price target


Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score


$0.52 (6.95%)


4 months 11 days ago

9/16 (56.25%)

$5.74 (28.97%)




1 years 4 months 6 days ago

3/3 (100%)

$5.47 (26.13%)



1 years 4 months 6 days ago

4/8 (50%)

$3.83 (13.28%)




$7.52 (100.53%)


1 years 6 months 24 days ago

5/6 (83.33%)

$1.18 (9.99%)




$4.52 (60.43%)


1 years 6 months 24 days ago

5/6 (83.33%)

$-2.3 (-6.16%)


Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Balaji Prasad is most bullish on?

Potential upside of $75.58 has been obtained for IDXX (IDEXX LABORATORIES)

Which stock is Balaji Prasad is most reserved on?

Potential downside of $4.7 has been obtained for CHRS (COHERUS BIOSCIENCES)

What Year was the first public recommendation made by Balaji Prasad?

On 2019

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart